men and women with moderate to severe opioid use disorder by Diagnostic and Statistical Manual, version 5, (DSM-V) criteria on a stable (at least one week without change) dose of oral buprenorphine-naloxone or methadone. (for OUD group)
Eligible participants will be between 18-60 years of age;
able to read at an eighth-grade level;
able to speak English.
You may not be if
unable to understand or complete the tasks.
Certain mental health conditions, including (but not limited to) bipolar I with current manic episode, schizophrenia, and schizoaffective disorder, determined by the Principal Investigator (PI) to interfere with study participation.
moderate or severe substance-use disorder (for Healthy Controls)
Clareo Health | Integrating Brain, Neurocognitive, and Computational Tools in OUD
